Epileptic seizure associated with intracerebroventricular and intrathecal morphine bolus.
We report on two patients with morphine-related seizures associated with either intrathecal or intracerebroventricular administration. Both patients had a history of malignant tumor and both experienced the seizures following bolus application of morphine, while even higher dosages were well tolerated when continuously infused. Seizures occurred without signs of intoxication. Initiation of intrathecal morphine therapy and bolus application should be performed carefully and only when constant monitoring is provided for at least 12 h. Animal data and possible mechanisms for morphine-related seizures are discussed.
Kronenberg
M F
MF
Department of Neurology, University Hospital Innsbruck, Austria.
Laimer
I
I
Rifici
C
C
Saltuari
L
L
Bramanti
P
P
Moriggl
U
U
Norer
B
B
Kofler
A
A
D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000503:physiopathology; D004827:Epilepsy / Q000139:chemically induced*; D006258:Head and Neck Neoplasms / Q000503:physiopathology; D006801:Humans; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D008297:Male; D009020:Morphine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010148:Intractable Pain / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000503:physiopathology
D000701:Analgesics, Opioid; D009020:Morphine